Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76,476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
Harris TD, Kalogeropoulos S, Nguyen T, Liu S, Bartis J, Ellars C, Edwards S, Onthank D, Silva P, Yalamanchili P, Robinson S, Lazewatsky J, Barrett J, Bozarth J. Harris TD, et al. Among authors: liu s. Cancer Biother Radiopharm. 2003 Aug;18(4):627-41. doi: 10.1089/108497803322287727. Cancer Biother Radiopharm. 2003. PMID: 14503959
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
Harris TD, Kalogeropoulos S, Nguyen T, Dwyer G, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Robinson S, Lazewatsky J, Barrett J. Harris TD, et al. Among authors: liu s. Bioconjug Chem. 2006 Sep-Oct;17(5):1294-313. doi: 10.1021/bc060063s. Bioconjug Chem. 2006. PMID: 16984141
Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.
Harris TD, Cheesman E, Harris AR, Sachleben R, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Silva P, Robinson S, Lazewatsky J, Rajopadhye M, Barrett J. Harris TD, et al. Among authors: liu s. Bioconjug Chem. 2007 Jul-Aug;18(4):1266-79. doi: 10.1021/bc070002+. Epub 2007 Jun 19. Bioconjug Chem. 2007. PMID: 17579472
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Barrett JA, Crocker AC, Damphousse DJ, Heminway SJ, Liu S, Edwards DS, Lazewatsky JL, Kagan M, Mazaika TJ, Carroll TR. Barrett JA, et al. Among authors: liu s. Bioconjug Chem. 1997 Mar-Apr;8(2):155-60. doi: 10.1021/bc970001p. Bioconjug Chem. 1997. PMID: 9095355
Biological evaluation of 99mTc-labeled cyclic glycoprotein IIb/IIIa receptor antagonists in the canine arteriovenous shunt and deep vein thrombosis models: effects of chelators on biological properties of [99mTc]chelator-peptide conjugates.
Barrett JA, Damphousse DJ, Heminway SJ, Liu S, Edwards DS, Looby RJ, Carroll TR. Barrett JA, et al. Among authors: liu s. Bioconjug Chem. 1996 Mar-Apr;7(2):203-8. doi: 10.1021/bc9500960. Bioconjug Chem. 1996. PMID: 8983342
76,476 results
You have reached the last available page of results. Please see the User Guide for more information.